NCT02276768 - Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

PainCancerColonic Disease

Interventions

DRUG

GIC-1001 375 mg TID

GIC-1001 375 mg TID mid-dose, oral tablet, white-coated, to be taken with water

DRUG

GIC-1001 500 mg TID

GIC-1001 500 mg TID high-dose, oral tablet, white-coated, to be taken with water

DRUG

GIC-1002 345 mg TID (equimolar to GIC-1001 375 mg TID)

GIC-1002 345 mg TID mid-dose, oral tablet, white-coated, to be taken with water

DRUG

GIC-1002 460 mg (equimolar to GIC-1001 500 mg)

GIC-1002 460 mg TID high-dose, oral tablet, white-coated, to be taken with water

OTHER

Placebo

Placebo identical and matching active drugs GIC-1001 and GIC-1001

Trial Locations (1)

Algorithme Pharma Inc., Montreal